Previous 10 |
PRQR +66% on positive interim results from Phase 1/2 clinical trial of QR-110 in LCA10 patients. More news on: ProQR Therapeutics, Cronos Group, Inc., Nevsun Resources Ltd., Stocks on the move, , Read more ...
LOS ANGELES , Sept. 5, 2018 /PRNewswire/ -- Stellar Biotechnologies, Inc. (Nasdaq: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy development pipelines targeting Alzheimer's, autoimmune disease and cancers, among other diseases, announced today that it h...
LOS ANGELES , Aug. 28, 2018 /PRNewswire/ -- Stellar Biotechnologies, Inc. (Nasdaq: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy development pipelines targeting Alzheimer's, lupus and cancers, among other diseases, announced today that Stellar CEO and P...
News, Short Squeeze, Breakout and More Instantly...
Stellar Biotechnologies Inc. Company Name:
SBOT Stock Symbol:
NASDAQ Market:
Stellar Biotechnologies Inc. Website:
Serve Robotics Inc. Announces Pricing of $40 Million Public Offering and Uplisting to the Nasdaq Capital Market Under New Ticker "SERV" PR Newswire SAN FRANCISCO , April 17, 2024 /PRNewswire/ -- Serve Robotics Inc. (the "Company" or "Serve"), a leading autono...
Serve Robotics Inc. Common Stock to Be Quoted on OTCQB Under Ticker Symbol "SBOT" PR Newswire SAN FRANCISCO , March 7, 2024 /PRNewswire/ -- Serve Robotics Inc. (the "Company" or "Serve"), a leading autonomous sidewalk delivery company, announces that ...
Edesa Biotech and Stellar Biotechnologies Complete Business Combination Canada NewsWire TORONTO, June 7, 2019 TORONTO , June 7, 2019 /CNW/ -- Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, today reported that the previously announced business combin...